Magnesium ion blockade of regional vasoconstriction.
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D003250:Constriction; D004285:Dogs; D004837:Epinephrine / Q000494:pharmacology; D008278:Magnesium Sulfate / Q000494:pharmacology / Q000627:therapeutic use*; D008638:Mesenteric Arteries / Q000187:drug effects / Q000502:physiology*; D009638:Norepinephrine / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D011189:Potassium Chloride / Q000494:pharmacology; D012077:Renal Artery / Q000187:drug effects / Q000502:physiology*; D012078:Renal Artery Obstruction / Q000188:drug therapy; D014662:Vasoconstrictor Agents / Q000494:pharmacology; D014666:Vasomotor System / Q000187:drug effects / Q000502:physiology; D014667:Vasopressins / Q000494:pharmacology
D014662:Vasoconstrictor Agents; D014667:Vasopressins; D000804:Angiotensin II; D010656:Phenylephrine; D011189:Potassium Chloride; D008278:Magnesium Sulfate; D009638:Norepinephrine; D004837:Epinephrine